Repatha Patent Expiration

Large Molecule Patents


Patent Number Company Patent Title Patent Expiry Activity Alert
US8030457 NA NA
May, 2029

(4 years from now)

Active


Ingredients:

Repatha contains Evolocumab as an active ingredient